HDAC inhibitor confers radiosensitivity to prostate stem-like cells

British Journal of Cancer

Volumn 109, Issue 12, 2013, Pages 3023-3033

  Frame, F M ^a   Pellacani, D ^a   Collins, A T ^a   Simms, M S ^b,c   Mann, V M ^c   Jones, Gdd ^d   Meuth, M ^e   Bristow, R G ^f   Maitland, N J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; TRICHOSTATIN A; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL POPULATION; CELL SURVIVAL; CELLULAR PARAMETERS; CLINICAL ARTICLE; COLONY FORMING EFFICIENCY; COMET ASSAY; DNA CROSS LINKING; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; FLOW CYTOMETRY; HETEROCHROMATIN; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; SINGLE STRANDED DNA BREAK; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COMET ASSAY; DNA DAMAGE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 84890434613     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.691     Document Type: Article

References (49)

1. Atadja PW (2011) HDAC inhibitors and cancer therapy. Prog Drug Res 67: 175-195.
2. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120): 756-760.
3. Belyaev IY (2010) Radiation-induced DNA repair foci: spatio-temporal aspects of formation, application for assessment of radiosensitivity and biological dosimetry. Mutat Res 704(1-3): 132-141.
4. Blanpain C, Mohrin M, Sotiropoulou PA, Passegue E (2011) DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8(1): 16-29.
5. Brawer MK (2002) Radiation therapy failure in prostate cancer patients: risk factors and methods of detection. Rev Urol 4(Suppl 2): S2-S11.
6. Bromfield GP, Meng A, Warde P, Bristow RG (2003) Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis 6(1): 73-85.
7. Burgess A, Ruefli A, Beamish H, Warrener R, Saunders N, Johnstone R, Gabrielli B (2004) Histone deacetylase inhibitors specifically kill nonproliferating tumour cells. Oncogene 23(40): 6693-6701.
8. Catton C, Milosevic M, Warde P, Bayley A, Crook J, Bristow R, Gospodarowicz M (2003) Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management. Urol Clin North Am 30(4): 751-763.
9. Chen K, Huang YH, Chen JL (2013) Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 34(6): 732-740.
10. Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT, Wong TT (2008) Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 3(5): e2090.
11. Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17(3): 313-319.
12. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23): 10946-10951.
13. Collins AT, Habib FK, Maitland NJ, Neal DE (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)- integrin expression. J Cell Sci 114(Pt 21): 3865-3872.
14. Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS (2012) Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109(8): 2784-2789.
15. Diehn M, Cho RW, Clarke MF (2009a) Therapeutic implications of the cancer stem cell hypothesis. Semin Radiat Oncol 19(2): 78-86.
16. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009b) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239): 780-783.
17. Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP, Stassi G (2008) Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 68(11): 4022-4025.
18. Frew AJ, Johnstone RW, Bolden JE (2009) Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett 280(2): 125-133.
19. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR (2001) Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49(2): 271-278.
20. Ishkanian AS, Zafarana G, Thoms J, Bristow RG (2010) Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncol 49(7): 888-894.
21. Jaamaa S, Af Hallstrom TM, Sankila A, Rantanen V, Koistinen H, Stenman UH, Zhang Z, Yang Z, De Marzo AM, Taari K, Ruutu M, Andersson LC, Laiho M (2010) DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. Cancer Res 70(21): 8630-8641.
22. Jones JS (2011) Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic. Eur Urol 60(3): 411-412.
23. Kiviharju-af Hallstrom TM, Jaamaa S, Monkkonen M, Peltonen K, Andersson LC, Medema RH, Peehl DM, Laiho M (2007) Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement. Proc Natl Acad Sci USA 104(17): 7211-7216.
24. Lang SH, Anderson E, Fordham R, Collins AT (2010) Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev 19(4): 537-546.
25. Lemay M, Wood KA (1999) Detection of DNA damage and identification of UV-induced photoproducts using the CometAssay kit. Biotechniques 27(4): 846-851.
26. Li L, Bhatia R (2011) Stem cell quiescence. Clin Cancer res 17(15): 4936-4941.
27. Mah LJ, El-Osta A, Karagiannis TC (2010) gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24(4): 679-686.
28. Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AC (2010) Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2(1): 47-61.
29. Marchion D, Munster P (2007) Development of histone deacetylase inhibitors for cancer treatment. Expert Rev Anticancer Ther 7(4): 583-598.
30. Miller SJ, Lavker RM, Sun TT (2005) Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim Biophys Acta 1756(1): 25-52.
31. Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, Morrison CG, Passegue E (2010) Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7(2): 174-185.
32. Nandhakumar S, Parasuraman S, Shanmugam MM, Rao KR, Chand P, Bhat BV (2011) Evaluation of DNA damage using single-cell gel electrophoresis (Comet Assay). J Pharmacol Pharmacother 2(2): 107-111.
33. Ostling O, Johanson KJ (1984) Microelectrophoretic study of radiationinduced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123(1): 291-298.
34. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10(15): 886-895.
35. Puck TT, Marcus PI (1956) Action of X-rays on mammalian cells. J Exp Med 103(5): 653-666.
36. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117(Pt 16): 3539-3545.
37. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175(1): 184-191.
38. Storch K, Eke I, Borgmann K, Krause M, Richter C, Becker K, Schrock E, Cordes N (2010) Three-dimensional cell growth confers radioresistance by chromatin density modification. Cancer Res 70(10): 3925-3934.
39. Sturmey RG, Hawkhead JA, Barker EA, Leese HJ (2009) DNA damage and metabolic activity in the preimplantation embryo. Hum Reprod 24(1): 81-91.
40. Swain U, Subba Rao K (2011) Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging. Mech Ageing Dev 132(8-9): 374-381.
41. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3): 206-221.
42. Toth KF, Knoch TA, Wachsmuth M, Frank-Stohr M, Stohr M, Bacher CP, Muller G, Rippe K (2004) Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J Cell Sci 117(Pt 18): 4277-4287.
43. Van Kooij RJ, de Boer P, De Vreeden-Elbertse JM, Ganga NA, Singh N, Te Velde ER (2004) The neutral comet assay detects double strand DNA damage in selected and unselected human spermatozoa of normospermic donors. Int J Androl 27(3): 140-146.
44. van Oorschot B, Hovingh SE, Rodermond H, Guclu A, Losekoot N, Geldof AA, Barendsen GW, Stalpers LJ, Franken NA (2013) Decay of gamma-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells. Oncol Rep 29(6): 2175-2180.
45. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10): 755-768.
46. Wojewodzka M, Buraczewska I, Kruszewski M (2002) A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody. Mutat Res 518(1): 9-20.
47. Woodward WA, Bristow RG (2009) Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Semin Radiat Oncol 19(2): 87-95.
48. Zafarana G, Bristow RG (2010) Tumor senescence and radioresistant tumorinitiating cells (TICs): let sleeping dogs lie! Breast Cancer Res 12(4): 111.
49. Zhang Z, Yang Z, Jaamaa S, Liu H, Pellakuru LG, Iwata T, Af Hallstrom TM, De Marzo AM, Laiho M (2011) Differential epithelium DNA damage response to ATM and DNA-PK pathway inhibition in human prostate tissue culture. Cell Cycle 10(20): 3545-3553.